Developer docs
API playgroundTry for free, no card

Search company profiles

Streuli Pharma

Full company profile

uuid000z2p4

Namestring
Streuli Pharma
Legal namestring
Streuli Pharma AG
Company typeenum
Private
Founded yearint
1867
Descriptiontext

Streuli Pharma AG is a privately held Swiss pharmaceutical manufacturer founded in 1867 and headquartered at Bahnhofstrasse 7 in Uznach (canton St. Gallen). The company produces prescription medications, specialty pharmaceuticals, generics, cosmetics, and dietary supplements at its single Uznach facility, where approximately 200 employees manufacture roughly 80 percent of the products in-house — yielding annual output of about 150 million tablets and capsules, 4 million ampoules, and various galenic forms (ointments, gels, suppositories). The portfolio covers analgesics, NSAIDs, corticosteroids, dermatologicals, cardiovascular, gastrointestinal, respiratory, urological, vitamin supplements, and CNS medications, plus a dedicated Dental line (notably the Rudocain local-anesthetic franchise) and Veterinary products.

The company operates a vertically organized, B2B sales-led go-to-market targeting physicians, dentists, hospitals, and pharmacies throughout Switzerland, with end-patient consumption downstream of those channels. All branded SKUs carry the 'Streuli' suffix and several legacy names (Acetalgin, Vitarubin, Dentohexin, Rudocain) function as standalone sub-brands; products are also discoverable via listing on the official Swiss Compendium drug reference. Revenue mechanics are standard pharma product sales (one-time licensing/purchase transactions through Swiss distribution), with pricing not publicly disclosed.

Ownership and governance are family-controlled: the company is in its fifth generation of family ownership and led by Claudia Streuli (Eidg. dipl. Apothekerin ETH) as Executive Chairwoman of the Board. Streuli Pharma AG operates as a Swiss Aktiengesellschaft (corporation) with no parent company, no subsidiaries, no institutional investors, and no disclosed M&A history. Operating status is active with ongoing recruitment, and the company's geographic footprint is exclusively Switzerland.

Short descriptiontext

Streuli Pharma AG is a Swiss family-owned pharmaceutical manufacturer founded in 1867 in Uznach, producing branded and generic prescription medications, dental anesthetics, and veterinary products exclusively for the Swiss healthcare market from its single-site facility.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersUznach, Switzerland
HQ citystring
Uznach
HQ countrystring
Switzerland
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
generic pharmaceutical manufacturing, prescription drug production, dental pharmaceutical products, veterinary pharmaceuticals, dietary supplement manufacturing
Industry3 codes
PRIMARYHLAIAAAA
Primary Care & General Medicine Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIABAL
Generic Hospital & Institutional Products
SECONDARYHLAMAEAM
Generic & Private-Label Veterinary Pharmaceuticals
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
NAICS code2 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Pharmaceutical and Medicine Manufacturing3254
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Generic and specialty pharmaceutical manufacturing
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Pharmaceutical Product Sales
TypeOne Time License
Description

Streuli Pharma generates revenue through the production and distribution of proprietary specialty pharmaceuticals and generic products for human, dental, and veterinary applications. The company sells prescription medications, cosmetics, and dietary supplements through Swiss pharmaceutical distribution channels.

streuli-pharma.ch
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 6 records shown
1Streuli
Description

Pharmaceutical products including prescription medications, generics, cosmetics, and dietary supplements for human use.

streuli-pharma.ch
+5 more records
Core offering1 text field

Streuli Pharma AG manufactures and distributes a comprehensive portfolio of proprietary specialty and generic pharmaceutical products for human, dental, and veterinary applications. The company produces prescription medications, over-the-counter products, cosmetics, and dietary supplements in multiple dosage forms including tablets, capsules, ampoules, ointments, gels, and suppositories. Approximately 80% of the product range is manufactured at the company's headquarters in Uznach, Switzerland.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Streuli Pharma AG is a Swiss pharmaceutical company with over 150 years of history that produces and distributes a comprehensive portfolio of medications across three main therapeutic areas: Human, Dental, and Veterinary. The company operates as a single unified product portfolio rather than a platform-plus-modules architecture. Their Human product range includes proprietary specialty medications and generic products (manufactured since 1971), organized into therapeutic categories: analgesics (Acetalgin®, Mefenacid®, ASA-Tabs®), corticosteroids (Prednisolon Streuli®, Prednison Streuli®), dermatological products (Bitumol®, Kamillex®, Pantothen-Streuli®, Vita-Hexin®), gout therapeutics (Uriconorm®, COLCTAB®), cardiovascular medications (Cinnageron®, Ephedrin Streuli®, Nitroglycerin Streuli®), local anesthetics (Lidocain Streuli®), gastrointestinal drugs (Loperamid Streuli®, Pantoprazol Streuli®, Prontolax®, Rudolac®), respiratory medications (Cetirizin Streuli®, Emedrin® N, Rinosedin®), urological products (Tamsulosin Streuli®), vitamin supplements (Vitarubin® variants, B1/B2/B6 Streuli®, Vitamin D3 Streuli®), CNS medications (Zolpidem Streuli®, Aphenylbarbit), and opioids (Hydromorphoni HCI Streuli®, Methadon Streuli®, Morphini HCI Streuli®). The Dental portfolio includes local anesthetics (Rudocain®, Rudocain® forte), analgesics (Mefenacid®, Acetalgin®), and oral care products (Dentohexin®, Angina MCC®). The company also produces cosmetics and nutritional supplements. Approximately 80% of products are manufactured at the Uznach facility, with annual production of around 150 million tablets and capsules, 4 million ampoules, and various galenic forms.

Product and service5 records
1Human Pharmaceuticals (proprietary and generic)
CategoryHuman pharmaceutical products
2Dental Pharmaceuticals
CategoryDental pharmaceutical products
3Veterinary Pharmaceuticals
CategoryVeterinary pharmaceutical products
4Cosmetics
CategoryCosmetics and personal care
5Dietary Supplements
CategoryDietary and nutritional supplements
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

European specialty pharmaceutical company focused on dermatology and primary care prescription products. Comparable in branded specialty positioning and HCP-led GTM, though larger and operating across multiple European markets.

TypeRegional player
Description

Leading Swiss pharmaceutical wholesaler and distributor serving pharmacies, hospitals, and physicians. Comparable Swiss pharma channel exposure and domestic reach; functions as a likely downstream partner/customer for Streuli rather than a direct competitor.

TypeDirect peer
Description

Swiss-headquartered specialty pharmaceutical company with branded prescription products in pain, CNS, and respiratory. Comparable mid-sized Swiss pharma with similar therapeutic breadth and physician/pharmacy channel mix.

TypeDirect peer
Description

Swiss pharmaceutical manufacturer and compounder supplying hospitals, pharmacies, and industry with specialties and galenics. Comparable in scale, Swiss-domestic orientation, and product mix including ampoules and galenic forms.

5Sandoz International GmbH
TypeBroad incumbent
Description

Global generics leader headquartered in Basel, Switzerland. Comparable in generics manufacturing and Swiss regulatory exposure, but vastly larger scale and global footprint versus Streuli's domestic-only model.

TypeDirect peer
Description

Swiss generics-focused pharmaceutical company selling through pharmacies and physicians across Switzerland. Directly comparable to Streuli's generics franchise with similar regulatory exposure to Swissmedic and BAG pricing.

TypeDirect peer
Description

Swiss specialty and generic pharmaceutical manufacturer serving dermatology, cardiometabolic, and OTC categories. Closely comparable to Streuli as a mid-sized Swiss pharma producer with a hybrid branded/generic portfolio and similar HCP distribution model.

TypeBroad incumbent
Description

European generics and specialty pharma group operating across multiple European markets. Comparable in generics/specialty mix and pharmacy-channel GTM, but materially larger and geographically broader than Streuli.

TypeBroad incumbent
Description

Global generics leader with a Swiss commercial entity (Teva/Mepha). Comparable in generics portfolio and Swiss pharmacy-channel distribution, but orders of magnitude larger than Streuli and operates across all major geographies.

TypeBroad incumbent
Description

European specialty pharmaceutical company with established brands across cardiovascular, urology, and primary care. Comparable therapeutic breadth and specialty pharma orientation, but with broader European footprint than Streuli.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Streuli Pharma

Generic and specialty pharmaceutical manufacturingstreuli-pharma.ch

Streuli Pharma AG is a Swiss family-owned pharmaceutical manufacturer founded in 1867 in Uznach, producing branded and generic prescription medications, dental anesthetics, and veterinary products exclusively for the Swiss healthcare market from its single-site facility.

What Streuli Pharma does

Streuli Pharma AG is a privately held Swiss pharmaceutical manufacturer founded in 1867 and headquartered at Bahnhofstrasse 7 in Uznach (canton St. Gallen). The company produces prescription medications, specialty pharmaceuticals, generics, cosmetics, and dietary supplements at its single Uznach facility, where approximately 200 employees manufacture roughly 80 percent of the products in-house — yielding annual output of about 150 million tablets and capsules, 4 million ampoules, and various galenic forms (ointments, gels, suppositories). The portfolio covers analgesics, NSAIDs, corticosteroids, dermatologicals, cardiovascular, gastrointestinal, respiratory, urological, vitamin supplements, and CNS medications, plus a dedicated Dental line (notably the Rudocain local-anesthetic franchise) and Veterinary products.

The company operates a vertically organized, B2B sales-led go-to-market targeting physicians, dentists, hospitals, and pharmacies throughout Switzerland, with end-patient consumption downstream of those channels. All branded SKUs carry the 'Streuli' suffix and several legacy names (Acetalgin, Vitarubin, Dentohexin, Rudocain) function as standalone sub-brands; products are also discoverable via listing on the official Swiss Compendium drug reference. Revenue mechanics are standard pharma product sales (one-time licensing/purchase transactions through Swiss distribution), with pricing not publicly disclosed.

Ownership and governance are family-controlled: the company is in its fifth generation of family ownership and led by Claudia Streuli (Eidg. dipl. Apothekerin ETH) as Executive Chairwoman of the Board. Streuli Pharma AG operates as a Swiss Aktiengesellschaft (corporation) with no parent company, no subsidiaries, no institutional investors, and no disclosed M&A history. Operating status is active with ongoing recruitment, and the company's geographic footprint is exclusively Switzerland.

Streuli Pharma firmographics

Firmographics
Name
Streuli Pharma
Legal name
Streuli Pharma AG
Website
https://streuli-pharma.ch
Company type
Private
Founded year
1867
Operating status
Operating
Headcount range
51–100 employees
Short description
Streuli Pharma AG is a Swiss family-owned pharmaceutical manufacturer founded in 1867 in Uznach, producing branded and generic prescription medications, dental anesthetics, and veterinary products exclusively for the Swiss healthcare market from its single-site facility.
Ownership category
akta.pro rank

Streuli Pharma industry classification

Industry
Product category
Generic and specialty pharmaceutical manufacturing
NAICS
Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAIAAAA
Primary Care & General Medicine Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIABAL
Generic Hospital & Institutional Products
SECONDARYHLAMAEAM
Generic & Private-Label Veterinary Pharmaceuticals
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics

Keywords

  • Generic pharmaceutical manufacturing
  • Prescription drug production
  • Dental pharmaceutical products
  • Veterinary pharmaceuticals
  • Dietary supplement manufacturing

Where Streuli Pharma is headquartered

Location

Headquarters

HQ city
Uznach
HQ country
Switzerland
HQ region
Europe

Offices1 record

Markets served

Streuli Pharma business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

  1. Pharmaceutical Product Sales: Streuli Pharma generates revenue through the production and distribution of proprietary specialty pharmaceuticals and generic products for human, dental, and veterinary applications. The company sells prescription medications, cosmetics, and dietary supplements through Swiss pharmaceutical distribution channels.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Streuli Pharma product offering

Product offering

Core offering

Streuli Pharma AG manufactures and distributes a comprehensive portfolio of proprietary specialty and generic pharmaceutical products for human, dental, and veterinary applications. The company produces prescription medications, over-the-counter products, cosmetics, and dietary supplements in multiple dosage forms including tablets, capsules, ampoules, ointments, gels, and suppositories. Approximately 80% of the product range is manufactured at the company's headquarters in Uznach, Switzerland.

Product overview

Streuli Pharma AG is a Swiss pharmaceutical company with over 150 years of history that produces and distributes a comprehensive portfolio of medications across three main therapeutic areas: Human, Dental, and Veterinary. The company operates as a single unified product portfolio rather than a platform-plus-modules architecture. Their Human product range includes proprietary specialty medications and generic products (manufactured since 1971), organized into therapeutic categories: analgesics (Acetalgin®, Mefenacid®, ASA-Tabs®), corticosteroids (Prednisolon Streuli®, Prednison Streuli®), dermatological products (Bitumol®, Kamillex®, Pantothen-Streuli®, Vita-Hexin®), gout therapeutics (Uriconorm®, COLCTAB®), cardiovascular medications (Cinnageron®, Ephedrin Streuli®, Nitroglycerin Streuli®), local anesthetics (Lidocain Streuli®), gastrointestinal drugs (Loperamid Streuli®, Pantoprazol Streuli®, Prontolax®, Rudolac®), respiratory medications (Cetirizin Streuli®, Emedrin® N, Rinosedin®), urological products (Tamsulosin Streuli®), vitamin supplements (Vitarubin® variants, B1/B2/B6 Streuli®, Vitamin D3 Streuli®), CNS medications (Zolpidem Streuli®, Aphenylbarbit), and opioids (Hydromorphoni HCI Streuli®, Methadon Streuli®, Morphini HCI Streuli®). The Dental portfolio includes local anesthetics (Rudocain®, Rudocain® forte), analgesics (Mefenacid®, Acetalgin®), and oral care products (Dentohexin®, Angina MCC®). The company also produces cosmetics and nutritional supplements. Approximately 80% of products are manufactured at the Uznach facility, with annual production of around 150 million tablets and capsules, 4 million ampoules, and various galenic forms.

Differentiator

Problem solved

Functional benefit

Brands

  • Streuli: Pharmaceutical products including prescription medications, generics, cosmetics, and dietary supplements for human use.
  • Rudocain
  • Acetalgin
  • Mefenacid
  • Dentohexin
  • Vitarubin

Products and services

  • Human Pharmaceuticals (proprietary and generic)
  • Dental Pharmaceuticals
  • Veterinary Pharmaceuticals
  • Cosmetics
  • Dietary Supplements

Companies that use Streuli Pharma

Customer profile

Named customers5 records

Segments3 records

Ideal customer profiles1 record

Streuli Pharma technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Streuli Pharma partnerships and signals

Strategic signal

Scale indicators5 records

Recent moves4 records

Expansion highlights4 records

Streuli Pharma competitors and assessment

Company assessment

Broad incumbents

  • Almirall S.A. European specialty pharmaceutical company focused on dermatology and primary care prescription products. Comparable in branded specialty positioning and HCP-led GTM, though larger and operating across multiple European markets.
  • Sandoz International GmbH: Global generics leader headquartered in Basel, Switzerland. Comparable in generics manufacturing and Swiss regulatory exposure, but vastly larger scale and global footprint versus Streuli's domestic-only model.
  • Stada Arzneimittel AG: European generics and specialty pharma group operating across multiple European markets. Comparable in generics/specialty mix and pharmacy-channel GTM, but materially larger and geographically broader than Streuli.
  • Teva Pharmaceutical Industries Ltd. Global generics leader with a Swiss commercial entity (Teva/Mepha). Comparable in generics portfolio and Swiss pharmacy-channel distribution, but orders of magnitude larger than Streuli and operates across all major geographies.
  • Recordati S.p.A. European specialty pharmaceutical company with established brands across cardiovascular, urology, and primary care. Comparable therapeutic breadth and specialty pharma orientation, but with broader European footprint than Streuli.

Regional players

  • Galexis AG: Leading Swiss pharmaceutical wholesaler and distributor serving pharmacies, hospitals, and physicians. Comparable Swiss pharma channel exposure and domestic reach; functions as a likely downstream partner/customer for Streuli rather than a direct competitor.

Direct peers

  • Gebro Pharma AG: Swiss-headquartered specialty pharmaceutical company with branded prescription products in pain, CNS, and respiratory. Comparable mid-sized Swiss pharma with similar therapeutic breadth and physician/pharmacy channel mix.
  • Hänseler AG: Swiss pharmaceutical manufacturer and compounder supplying hospitals, pharmacies, and industry with specialties and galenics. Comparable in scale, Swiss-domestic orientation, and product mix including ampoules and galenic forms.
  • Mepha Pharma AG: Swiss generics-focused pharmaceutical company selling through pharmacies and physicians across Switzerland. Directly comparable to Streuli's generics franchise with similar regulatory exposure to Swissmedic and BAG pricing.
  • Spirig HealthCare AG: Swiss specialty and generic pharmaceutical manufacturer serving dermatology, cardiometabolic, and OTC categories. Closely comparable to Streuli as a mid-sized Swiss pharma producer with a hybrid branded/generic portfolio and similar HCP distribution model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Streuli Pharma social profiles

Digital presence

Streuli Pharma financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Streuli Pharma leadership team

Management profile

Number of profiles

Profiles1 record

Streuli Pharma funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Streuli Pharma M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Streuli Pharma

What does Streuli Pharma do?

Streuli Pharma AG manufactures and distributes a comprehensive portfolio of proprietary specialty and generic pharmaceutical products for human, dental, and veterinary applications. The company produces prescription medications, over-the-counter products, cosmetics, and dietary supplements in multiple dosage forms including tablets, capsules, ampoules, ointments, gels, and suppositories. Approximately 80% of the product range is manufactured at the company's headquarters in Uznach, Switzerland.

Is Streuli Pharma a public or private company?

Streuli Pharma is a private company. It is classified as family owned and is currently operating.

When was Streuli Pharma founded?

Streuli Pharma was founded in 1867. It employs 51 to 100 people.

Where is Streuli Pharma based?

Streuli Pharma is headquartered in Uznach, Switzerland, in the Europe region.

How does Streuli Pharma make money?

One revenue line is on record: pharmaceutical Product Sales.

Who are Streuli Pharma's main competitors?

Broad incumbents on record are Almirall S.A., Sandoz International GmbH, Stada Arzneimittel AG, Teva Pharmaceutical Industries Ltd. and Recordati S.p.A.. Galexis AG is listed as a regional player. Direct peers are Gebro Pharma AG, Hänseler AG, Mepha Pharma AG and Spirig HealthCare AG.

Does Streuli Pharma have an API?

No public API is recorded for Streuli Pharma.

What industry is Streuli Pharma in?

Streuli Pharma's product category is Generic and specialty pharmaceutical manufacturing. Its primary akta.pro industry code is HLAIAAAA, Primary Care & General Medicine Pharmaceuticals, with a secondary code of HLAIABAL, Generic Hospital & Institutional Products. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales